ABBV Stock: Buy Before Earnings or Wait? | $300 Target or 10% Drop?

Описание: Is AbbVie (NYSE: ABBV) a buy before earnings, or is it better to wait?

In this video, we take a deep dive into AbbVie (ABBV) stock by analyzing its latest price action, technical chart, valuation, earnings expectations, analyst price targets, and long-term fundamentals.

We discuss whether ABBV can break above resistance and move toward the $300 price target, or if investors should expect a pullback after earnings.

In This Video:

📊 ABBV Technical Analysis

💰 Earnings Preview (EPS & Revenue Expectations)

📈 Bullish & Bearish Price Targets

🏥 Fundamental Analysis

⚠️ Key Support & Resistance Levels

🎯 Buy Before Earnings or Wait?


If you enjoy stock market analysis and long-term investing content, please Like, Subscribe, and turn on notifications so you never miss future updates.

Disclaimer: This video is for educational and informational purposes only and should not be considered financial or investment advice. Always do your own research before making any investment decisions.

#ABBV #AbbVie #StockAnalysis #DividendStocks #StockMarket #Investing #Earnings #PharmaStocks #NYSE #LongTermInvesting #ValueInvesting #StocksToBuy